Chen R C, McLeod J G
Department of Medicine, University of Sydney, NSW.
Clin Exp Neurol. 1989;26:99-112.
The medical records of 285 patients at Royal Prince Alfred Hospital with a definite diagnosis of sarcoidosis over the period 1973-87 were reviewed. Fourteen (4.9%) had involvement of the nervous system, in 8 of whom the neurological manifestations were the presenting feature of the disease. The age range of neurosarcoidosis was 22 to 79 years and there was a female preponderance (10:4). Neurological complications (some patients experienced more than one complication) were facial nerve palsy (4), myopathy (3), aseptic meningitis (3), deafness/vertigo (2), hydrocephalus (2), hypopituitarism (2) and peripheral neuropathy (1). Most patients received corticosteroid therapy. Two patients required neurosurgical management for hydrocephalus and 1 for pituitary sarcoid. The frequency and type of neurological complications in this Australian study are similar to those reported from the Northern Hemisphere.
回顾了1973年至1987年间在皇家阿尔弗雷德王子医院明确诊断为结节病的285例患者的病历。其中14例(4.9%)累及神经系统,8例患者的神经表现为该疾病的首发特征。神经结节病的年龄范围为22至79岁,女性居多(10:4)。神经并发症(部分患者有不止一种并发症)包括面神经麻痹(4例)、肌病(3例)、无菌性脑膜炎(3例)、耳聋/眩晕(2例)、脑积水(2例)、垂体功能减退(2例)和周围神经病变(1例)。大多数患者接受了皮质类固醇治疗。2例患者因脑积水需要神经外科治疗,1例因垂体结节病需要治疗。这项澳大利亚研究中神经并发症的频率和类型与北半球报告的相似。